Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial
Borg, T., Gaballah, A., Khallaf, M., Hemeda, H., Elkady, M. (2022). Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial. EKB Journal Management System, 12(2), 166-176. doi: 10.21608/ebwhj.2022.116590.1165
Tamer Borg; Asmaa Gaballah; Mohamed S. Khallaf; Hossam Hemeda; Marwan Elkady. "Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial". EKB Journal Management System, 12, 2, 2022, 166-176. doi: 10.21608/ebwhj.2022.116590.1165
Borg, T., Gaballah, A., Khallaf, M., Hemeda, H., Elkady, M. (2022). 'Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial', EKB Journal Management System, 12(2), pp. 166-176. doi: 10.21608/ebwhj.2022.116590.1165
Borg, T., Gaballah, A., Khallaf, M., Hemeda, H., Elkady, M. Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial. EKB Journal Management System, 2022; 12(2): 166-176. doi: 10.21608/ebwhj.2022.116590.1165

Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial

Evidence Based Women's Health Journal
Article 5, Volume 12, Issue 2, May 2022, Page 166-176  XML PDF (1.29 MB)
Document Type: Original Article
DOI: 10.21608/ebwhj.2022.116590.1165
View on SCiNiTO View on SCiNiTO
Authors
Tamer Borg1; Asmaa Gaballah email 2; Mohamed S. Khallaf3; Hossam Hemeda2; Marwan Elkady4
1Department of Obstetrics and Gynecology Faculty of Medicine – Ain Shams University
2Obstetrics and gynecology Ain shams university Cairo Egypt
3Department of Obstetrics & Gynaecology, Faculty of Medicine, Ain Shams University
4Obstetrics and gynecology Faculty of medicine Ain shams university Cairo Egypt
Abstract
Aim: This study aimed to explore the effect of chromium picolinate compared to Metformin supplementation with ovulation induction in polycystic ovary syndrome, In particular, its effect on insulin sensitivity, ovarian response and pregnancy rate.
Materials and Methods: This study was conducted as a prospective study, aimed to compare the effect of Chromium and Metformin supplementations on ovulation rate in Polycystic ovary patients undergoing ovulation induction. The present study included 140 women divided into 2 groups each is 70 infertile women diagnosed as polycystic ovary syndrome according to Rotterdam criteria 2017: (oligo-ovulation or anovulation, clinical or biochemical signs of hyperandrogenism, polycystic ovaries on ultrasound).
Results: Fasting blood sugar (FBS) and fasting insulin level were significantly decreased in metformin group than in Chromium picolinate group after 3 months of treatment (p=0.006) (p=0.026) respectively. Testosterone significantly decreased in both groups at follow up as compared to basal level (P-value <0.001, Conclusion: In view of the aforementioned findings, we recommend that metformin could be replaced by chromium picolinate in some PCOS patients, as its better tolerated than metformin due to lower side effects and no significant differences were observed between the two groups regarding ovulation and pregnancy rates.
Keywords
Chromium picolinate; Clomiphen citrate; Metformin; Polycystic ovary Syndrome (PCOS)
Statistics
Article View: 302
PDF Download: 1,459